These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 18847196)
21. Anti-infective therapy using species-specific activators of Staphylococcus aureus ClpP. Wei B; Zhang T; Wang P; Pan Y; Li J; Chen W; Zhang M; Ji Q; Wu W; Lan L; Gan J; Yang CG Nat Commun; 2022 Nov; 13(1):6909. PubMed ID: 36376309 [TBL] [Abstract][Full Text] [Related]
22. Quercetin Reduces the Virulence of S. aureus by Targeting ClpP to Protect Mice from MRSA-Induced Lethal Pneumonia. Jing S; Kong X; Wang L; Wang H; Feng J; Wei L; Meng Y; Liu C; Chang X; Qu Y; Guan J; Yang H; Zhang C; Zhao Y; Song W Microbiol Spectr; 2022 Apr; 10(2):e0234021. PubMed ID: 35319277 [TBL] [Abstract][Full Text] [Related]
23. In vitro percutaneous absorption of 14C-labeled β-lactone promises topical delivery of new bacterial virulence inhibitors. Lorenz-Baath K; Korotkov VS; Lierse von Gostomski C; Sieber SA ChemMedChem; 2012 Aug; 7(8):1490-5. PubMed ID: 22786798 [TBL] [Abstract][Full Text] [Related]
24. Trapping and proteomic identification of cellular substrates of the ClpP protease in Staphylococcus aureus. Feng J; Michalik S; Varming AN; Andersen JH; Albrecht D; Jelsbak L; Krieger S; Ohlsen K; Hecker M; Gerth U; Ingmer H; Frees D J Proteome Res; 2013 Feb; 12(2):547-58. PubMed ID: 23253041 [TBL] [Abstract][Full Text] [Related]
25. Bacterial caseinolytic proteases as novel targets for antibacterial treatment. Brötz-Oesterhelt H; Sass P Int J Med Microbiol; 2014 Jan; 304(1):23-30. PubMed ID: 24119566 [TBL] [Abstract][Full Text] [Related]
26. Nepetin reduces virulence factors expression by targeting ClpP against MRSA-induced pneumonia infection. Jing S; Ren X; Wang L; Kong X; Wang X; Chang X; Guo X; Shi Y; Guan J; Wang T; Wang B; Song W; Zhao Y Virulence; 2022 Dec; 13(1):578-588. PubMed ID: 35363605 [TBL] [Abstract][Full Text] [Related]
27. α-Amino Diphenyl Phosphonates as Novel Inhibitors of Escherichia coli ClpP Protease. Moreno-Cinos C; Sassetti E; Salado IG; Witt G; Benramdane S; Reinhardt L; Cruz CD; Joossens J; Van der Veken P; Brötz-Oesterhelt H; Tammela P; Winterhalter M; Gribbon P; Windshügel B; Augustyns K J Med Chem; 2019 Jan; 62(2):774-797. PubMed ID: 30571121 [TBL] [Abstract][Full Text] [Related]
28. The development of small-molecule modulators for ClpP protease activity. Ye F; Li J; Yang CG Mol Biosyst; 2016 Dec; 13(1):23-31. PubMed ID: 27831584 [TBL] [Abstract][Full Text] [Related]
29. Extracellular proteases of Staphylococcus spp. Dubin G Biol Chem; 2002; 383(7-8):1075-86. PubMed ID: 12437090 [TBL] [Abstract][Full Text] [Related]
30. The ClpXP protease is dispensable for degradation of unfolded proteins in Staphylococcus aureus. Stahlhut SG; Alqarzaee AA; Jensen C; Fisker NS; Pereira AR; Pinho MG; Thomas VC; Frees D Sci Rep; 2017 Sep; 7(1):11739. PubMed ID: 28924169 [TBL] [Abstract][Full Text] [Related]
31. Characterization for enterotoxin production, virulence factors, and antibiotic susceptibility of Staphylococcus aureus isolates from various foods in Portugal. Pereira V; Lopes C; Castro A; Silva J; Gibbs P; Teixeira P Food Microbiol; 2009 May; 26(3):278-82. PubMed ID: 19269569 [TBL] [Abstract][Full Text] [Related]
32. Alcohol increases hemolysis by staphylococci. Korem M; Gov Y; Shirron N; Shuster A; Rosenberg M FEMS Microbiol Lett; 2007 Apr; 269(1):153-9. PubMed ID: 17227454 [TBL] [Abstract][Full Text] [Related]
33. The development of first Staphylococcus aureus SplB protease inhibitors: phosphonic analogues of glutamine. Ewa B; Maciej W; Marcin S; Grzegorz D; Michał Z; Jan P; Józef O Bioorg Med Chem Lett; 2012 Sep; 22(17):5574-8. PubMed ID: 22858096 [TBL] [Abstract][Full Text] [Related]
35. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Lawrence KR; Golik MV; Davidson L Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720 [TBL] [Abstract][Full Text] [Related]
36. Clinical isolates of Staphylococcus aureus from the Arkhangelsk region, Russia: antimicrobial susceptibility, molecular epidemiology, and distribution of Panton-Valentine leukocidin genes. Vorobieva V; Bazhukova T; Hanssen AM; Caugant DA; Semenova N; Haldorsen BC; Simonsen GS; Sundsfjord A APMIS; 2008 Oct; 116(10):877-87. PubMed ID: 19132981 [TBL] [Abstract][Full Text] [Related]
37. Tailored Peptide Phenyl Esters Block ClpXP Proteolysis by an Unusual Breakdown into a Heptamer-Hexamer Assembly. Lakemeyer M; Bertosin E; Möller F; Balogh D; Strasser R; Dietz H; Sieber SA Angew Chem Int Ed Engl; 2019 May; 58(21):7127-7132. PubMed ID: 30829431 [TBL] [Abstract][Full Text] [Related]
38. Tailored Phenyl Esters Inhibit ClpXP and Attenuate Staphylococcus aureus α-Hemolysin Secretion. Schwarz M; Hübner I; Sieber SA Chembiochem; 2022 Aug; 23(16):e202200253. PubMed ID: 35713329 [TBL] [Abstract][Full Text] [Related]
39. High-Throughput Screening Strategies for the Development of Anti-Virulence Inhibitors Against Staphylococcus aureus. Cai X; Zheng W; Li Z Curr Med Chem; 2019; 26(13):2297-2312. PubMed ID: 29165063 [TBL] [Abstract][Full Text] [Related]
40. Functional Characterisation of ClpP Mutations Conferring Resistance to Acyldepsipeptide Antibiotics in Firmicutes. Malik IT; Pereira R; Vielberg MT; Mayer C; Straetener J; Thomy D; Famulla K; Castro H; Sass P; Groll M; Brötz-Oesterhelt H Chembiochem; 2020 Jul; 21(14):1997-2012. PubMed ID: 32181548 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]